{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:07:07Z","timestamp":1792624027018,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-96879-7","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:46:34Z","timestamp":1743828394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of the location and severity of partial ureteral obstruction on urinary system stone disease formation"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1373-5239","authenticated-orcid":false,"given":"Kemal","family":"Demirhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8904-1612","authenticated-orcid":false,"given":"Hasan Salih","family":"Saglam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0824-3926","authenticated-orcid":false,"given":"Haci Ibrahim","family":"Cimen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2425-522X","authenticated-orcid":false,"given":"Bilge","family":"Elcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6205-5109","authenticated-orcid":false,"given":"Erdem","family":"Cokluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"issue":"4","key":"96879_CR1","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41581-021-00513-4","volume":"18","author":"P Singh","year":"2022","unstructured":"Singh, P., Harris, P. C., Sas, D. J. & Lieske, J. C. The genetics of kidney stone disease and nephrocalcinosis. Nat. Rev. Nephrol. 18 (4), 224\u2013240. https:\/\/doi.org\/10.1038\/s41581-021-00513-4 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"96879_CR2","doi-asserted-by":"publisher","first-page":"1203640","DOI":"10.3389\/fpubh.2023.1203640","volume":"11","author":"NI Dirie","year":"2023","unstructured":"Dirie, N. I. et al. The prevalence of urolithiasis in subjects undergoing computer tomography in selected referral diagnostic centers in Mogadishu, Somalia. Front. Public. Health. 11, 1203640. https:\/\/doi.org\/10.3389\/fpubh.2023.1203640 (2023).","journal-title":"Front. Public. Health"},{"key":"96879_CR3","unstructured":"Song, L., Maalouf, N. M. & Nephrolithiasis [Updated 2020 Mar 9]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279069\/ Accessed 8 December 2024."},{"issue":"8","key":"96879_CR4","first-page":"490","volume":"99","author":"LF Fontenelle","year":"2019","unstructured":"Fontenelle, L. F. & Sarti, T. D. Kidney stones: treatment and prevention. Am. Family Phys. 99 (8), 490\u2013496 (2019).","journal-title":"Am. Family Phys."},{"issue":"3","key":"96879_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1365-2613.2010.00727.x","volume":"92","author":"J Klein","year":"2011","unstructured":"Klein, J. et al. Congenital ureteropelvic junction obstruction: human disease and animal models. Int. J. Exp. Pathol. 92 (3), 168\u2013192. https:\/\/doi.org\/10.1111\/j.1365-2613.2010.00727.x (2011).","journal-title":"Int. J. Exp. Pathol."},{"issue":"2","key":"96879_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/jcp.2004.019588","volume":"58","author":"TM Reynolds","year":"2005","unstructured":"Reynolds, T. M. ACP best practice 181: chemical pathology clinical investigation and management of nephrolithiasis. J. Clin. Pathol. 58 (2), 134\u2013140. https:\/\/doi.org\/10.1136\/jcp.2004.019588 (2005).","journal-title":"J. Clin. Pathol."},{"issue":"5","key":"96879_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.purol.2023.01.006","volume":"33","author":"G Krings","year":"2023","unstructured":"Krings, G. et al. Ureteropelvic junction obstruction and renal calculi: simultaneous treatment by robot-assisted laparoscopic pyeloplasty and transcutaneous retrograde flexible ureteroscopy. Technique description and early outcomes. Progres En urologie: journal de l\u2019association Francaise d\u2019urologie. Et De La. Societe Francaise D\u2019urologie. 33 (5), 279\u2013284. https:\/\/doi.org\/10.1016\/j.purol.2023.01.006 (2023).","journal-title":"Et De La. Societe Francaise D\u2019urologie"},{"issue":"3","key":"96879_CR8","doi-asserted-by":"publisher","first-page":"e2246","DOI":"10.1002\/rcs.2246","volume":"17","author":"S Scarcella","year":"2021","unstructured":"Scarcella, S. et al. Combined treatment of ureteropelvic junction obstruction and renal calculi with robot-assisted laparoscopic pyeloplasty and laser lithotripsy in children: case report and non-systematic review of the literature. Int. J. Med. Rob. + Comput. Assist. Surgery: MRCAS. 17 (3), e2246. https:\/\/doi.org\/10.1002\/rcs.2246 (2021).","journal-title":"Int. J. Med. Rob. + Comput. Assist. Surgery: MRCAS"},{"issue":"5-6","key":"96879_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.plefa.2009.03.002","volume":"80","author":"M Takenaka","year":"2009","unstructured":"Takenaka, M. et al. Effect of Beraprost sodium (BPS) in a new rat partial unilateral ureteral obstruction model. Prostaglandins Leukot. Essent. Fat. Acids. 80 (5-6), 263\u2013267. https:\/\/doi.org\/10.1016\/j.plefa.2009.03.002 (2009).","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"5","key":"96879_CR10","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1359\/jbmr.081245","volume":"24","author":"A Okada","year":"2009","unstructured":"Okada, A. et al. Genome-wide analysis of genes related to kidney stone formation and elimination in the calcium oxalate nephrolithiasis model mouse: detection of stone-preventive factors and involvement of macrophage activity. J. Bone Mineral. Research: Official J. Am. Soc. Bone Mineral. Res. 24 (5), 908\u2013924. https:\/\/doi.org\/10.1359\/jbmr.081245 (2009).","journal-title":"J. Bone Mineral. Research: Official J. Am. Soc. Bone Mineral. Res."},{"issue":"2","key":"96879_CR11","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3906\/sag-1802-17","volume":"49","author":"S \u00c7imen","year":"2019","unstructured":"\u00c7imen, S. et al. Protective effects of Ghrelin on kidney tissue in rats with partial ureteral obstruction. Turk. J. Med. Sci. 49 (2), 696\u2013702. https:\/\/doi.org\/10.3906\/sag-1802-17 (2019).","journal-title":"Turk. J. Med. Sci."},{"issue":"1","key":"96879_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7243\/2055-091X-3-1","volume":"3","author":"U Khalid","year":"2016","unstructured":"Khalid, U. et al. Kidney ischaemia reperfusion injury in the rat: the EGTI scoring system as a valid and reliable tool for histological assessment. J. Histol. Histopathology. 3 (1), 1. https:\/\/doi.org\/10.7243\/2055-091X-3-1 (2016).","journal-title":"J. Histol. Histopathology"},{"key":"96879_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1177\/12.5.333","volume":"12","author":"P Pizzolato","year":"1964","unstructured":"Pizzolato, P. Histochemical recognition of calcium oxalate. J. Histochem. Cytochemistry: Official J. Histochem. Soc. 12, 333\u2013336. https:\/\/doi.org\/10.1177\/12.5.333 (1964).","journal-title":"J. Histochem. Cytochemistry: Official J. Histochem. Soc."},{"issue":"1","key":"96879_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1080\/0886022X.2016.1256318","volume":"39","author":"W Zhu","year":"2017","unstructured":"Zhu, W. et al. Establishment and observation of a new and ideal reversible model of PUUO. Ren. Fail. 39 (1), 222\u2013228. https:\/\/doi.org\/10.1080\/0886022X.2016.1256318 (2017).","journal-title":"Ren. Fail."},{"key":"96879_CR15","doi-asserted-by":"publisher","unstructured":"Williams, J. C., Gambaro, G., Rodgers, A., Asplin, J., Bonny, O., Costa-Bauz\u00e1, A.,Ferraro, P. M., Fogazzi, G., Fuster, D. G., Goldfarb, D. S., Grases, F., Heilberg,I. P., Kok, D., Letavernier, E., Lippi, G., Marangella, M., Nouvenne, A., Petrarulo,M., Siener, R., Robertson, W. G. Urine and stone analysis for the investigation of the renal stone former: a consensus conference. Urolithiasis, 49(1), 1\u201316. https:\/\/doi.org\/10.1007\/s00240-020-01217-3 (2021).","DOI":"10.1007\/s00240-020-01217-3"},{"issue":"5","key":"96879_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00240-020-01177-8","volume":"48","author":"A Rodriguez","year":"2020","unstructured":"Rodriguez, A., Baccaro, R., Gambaro, G. & Ferraro, P. M. Urinary supersaturation on fractioned urine collections: which urine sample can explain better the variability observed on 24-h urine? A proof-of-concept study. Urolithiasis 48 (5), 403\u2013408. https:\/\/doi.org\/10.1007\/s00240-020-01177-8 (2020).","journal-title":"Urolithiasis"},{"issue":"11","key":"96879_CR17","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s00431-020-03662-z","volume":"179","author":"Y Paccaud","year":"2020","unstructured":"Paccaud, Y. et al. Spot urine samples to estimate 24-hour urinary calcium excretion in school-age children. Eur. J. Pediatrics. 179 (11), 1673\u20131681. https:\/\/doi.org\/10.1007\/s00431-020-03662-z (2020).","journal-title":"Eur. J. Pediatrics"},{"issue":"8","key":"96879_CR18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.34067\/KID.0000000000000184","volume":"4","author":"EA Adomako","year":"2023","unstructured":"Adomako, E. A., Li, X., Sakhaee, K., Moe, O. W. & Maalouf, N. M. Urine pH and citrate as predictors of calcium phosphate stone formation. Kidney360 4 (8), 1123\u20131129. https:\/\/doi.org\/10.34067\/KID.0000000000000184 (2023).","journal-title":"Kidney360"},{"key":"96879_CR19","doi-asserted-by":"publisher","unstructured":"Alelign, T. & Petros, B. Kidney Stone Disease: An Update on Current Concepts. Adv. Urol. 2018, 3068365. https:\/\/doi.org\/10.1155\/2018\/3068365 (2018).","DOI":"10.1155\/2018\/3068365"},{"issue":"5","key":"96879_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00240-020-01202-w","volume":"48","author":"R Geraghty","year":"2020","unstructured":"Geraghty, R., Wood, K. & Sayer, J. A. Calcium oxalate crystal deposition in the kidney: identification, causes and consequences. Urolithiasis 48 (5), 377\u2013384. https:\/\/doi.org\/10.1007\/s00240-020-01202-w (2020).","journal-title":"Urolithiasis"},{"issue":"1","key":"96879_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12894-022-01017-4","volume":"22","author":"K Wang","year":"2022","unstructured":"Wang, K. et al. Risk factors for kidney stone disease recurrence: a comprehensive meta-analysis. BMC Urol. 22 (1), 62. https:\/\/doi.org\/10.1186\/s12894-022-01017-4 (2022).","journal-title":"BMC Urol."},{"issue":"9","key":"96879_CR22","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s11255-021-02879-7","volume":"53","author":"V Solak","year":"2021","unstructured":"Solak, V., G\u00f6kce, M. \u0130. & Yaman, \u00d6. Potassium citrate vs. hydrochlorothiazide to reduce urinary calcium excretion in calcium oxalate stone patients with hypercalciuria: a prospective randomized study. Int. Urol. Nephrol. 53 (9), 1791\u20131796. https:\/\/doi.org\/10.1007\/s11255-021-02879-7 (2021).","journal-title":"Int. Urol. Nephrol."},{"issue":"4","key":"96879_CR23","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00467-022-05684-1","volume":"38","author":"W Hayes","year":"2023","unstructured":"Hayes, W. et al. Efficacy and safety of Lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial. Pediatr. Nephrol. 38 (4), 1075\u20131086. https:\/\/doi.org\/10.1007\/s00467-022-05684-1 (2023).","journal-title":"Pediatr. Nephrol."},{"key":"96879_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-025-04369-6","author":"AK Moaveni","year":"2025","unstructured":"Moaveni, A. K., Neishabouri, A., Paymani, Z., Haghighi, F. & Kajbafzadeh, A. M. Supranormal renal function in pediatric ureteropelvic junction obstruction: a multiparameter analysis to guide clinical management. Int. Urol. Nephrol. https:\/\/doi.org\/10.1007\/s11255-025-04369-6 (2025).","journal-title":"Int. Urol. Nephrol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96879-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96879-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96879-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:46:49Z","timestamp":1743828409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96879-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["96879"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-96879-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"We confirm that this study is implemented in accordance with the Animal Research Reporting in Live Experiments (ARRIVE) guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"The questionnaire and methodology for this study was approved by the Sakarya University Animal Experiments Local Ethics Committee. (Ethics approval number:22, 06\/04\/2022). A scanned copy of the ethics review approval document has been uploaded to the submission website.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"11560"}}